<DOC>
	<DOCNO>NCT00726674</DOCNO>
	<brief_summary>Treatment diabetes mellitus type II basal insulin , patient treat Clalit outpatient clinic adequately control current treatment .</brief_summary>
	<brief_title>Basal Insulin Type 2 Diabetes Patients Treated Outpatient Clalit Clinics</brief_title>
	<detailed_description>Patients diabetes treated outpatient clinic recruit primary care physician . Recruitment period 3 month per center patient follow 7 month Diabetes specialist responsible 50-65 primary care physician . The specialist advise direct primary care physician whole study period . The study protocol include patient treat different type non short- acting insulin . Insulin Lantus ( include dose ) start primary physician , need consult Diabetes Specialist . The treatment follow study protocol . Patients 3 pre-scheduled visit clinic : 1 . At begin study . 2 . After 3 month . 3 . At study end ( 6 month ) . An additional telephone contact take place 1 month last visit . evaluate adherence therapy Data collecting : Data include HbA1c , FPG , current diabetic treatment , dose insulin Lantus , relevant additional diseases\complaints collect visit . Additional information demographic data , medical history collect begin study . Safety : Hypoglycaemic episode record</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 . Type II Diabetic patient 2 . HbA1c &gt; 8.0 % ( result precede 4 month ) 3 . Written inform consent 4 . Life expectancy least 1 year . 5 . Patients ' agree discontinue current long act insulin ( applicable ) . 6 . Patients accord GP eligible study . 1 . Type I diabetes 2 . Pregnancy and\or lactation . 3 . Allergy basal insulin 4 . Patients suffer disease require repeat hospitalization E.g . : severe CHF , sever renal failure , active malignancy . 5 . Patients able give consent . 6 . Patients face difficulty mobility and/or verbal communication treat physician . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Diabetes HbA1C</keyword>
</DOC>